title: Is there a role for perioperative adjuvant cytotoxic therapy in the treatment of early breast cancer?
authors.affiliation: CRC Clinical Trials Centre, Rayne Institute, London, Great Britain.
authors.forename: J
authors.initials: J
authors.lastname: Houghton
authors.forename: M
authors.initials: M
authors.lastname: Baum
authors.forename: R
authors.initials: R
authors.lastname: Nissen-Meyer
authors.forename: D
authors.initials: D
authors.lastname: Riley
authors.forename: R A
authors.initials: RA
authors.lastname: Hern
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D013629:Tamoxifen / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D013629:Tamoxifen; D003520:Cyclophosphamide